Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
Lorytec 10 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablets. White to off-white, round, flat tablets, 8mm diameter, scored on one side. The score line of the tablet is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each tablet contains 10 mg loratadine.
Excipient(s) with known effect: The quantity of lactose in the loratadine 10 mg tablet composition is 60.00 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Loratadine |
Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage. |
| List of Excipients |
|---|
|
Lactose |
Blisters of Aluminum/PVC.
Pack size:
1 blisters x 10 tablets
2 blisters x 10 tablets
3 blisters x 10 tablets
Delorbis Pharmaceuticals Ltd., 17 Athinon Street, Ergates Industrial Area, 2643 Ergates, P.O. Box 28629, 2081 Lefkosia, Cyprus, European Union
019330
Date of first authorization: 29May 2001
Date of latest renewal: 28 May 2011
| Drug | Countries | |
|---|---|---|
| LORYTEC | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
